<!DOCTYPE html>
<html lang="en">
<head><!-- Google Tag Manager --> <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-N4XZHNC');</script> <!-- End Google Tag Manager -->

<title>Botulinum Toxin A: Mechanism, Adverse Effects and Contraindications</title>
  <meta charset="utf-8">
  
  <link href="urology2.css" rel="stylesheet">

<meta name="keywords" content="Botulinum Toxin A, neurogenic lower urinary tract dysfunction, overactive bladder" >
<meta name="description" content="Pharmacological profile of Botulinum Toxin A for the treatment of neurogenic lower urinary tract dysfunction and overactive bladder..., from the online textbook of urology by D. Manski" >
<meta name="author" content="Dr. med. Dirk Manski" >
<meta name="copyright" content="Dirk Manski" >
<meta name="robots" content="index">
<meta name="robots" content="follow">
<meta name="viewport" content="width=device-width, initial-scale=1">
 </head>

<body><!-- Google Tag Manager (noscript) --> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-N4XZHNC" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> 
<header>
    <a class="ribbon" tabindex="-1" title="back to start!" href="https://www.urology-textbook.com/index.html">
	   <p><span style="font-size: 1.2em;">Urology Textbook</span><br>
       
       <span style="font-size: 0.8em;">Clinical Essentials</span>
       <br>
       <span style="font-size: 0.6em;">By Dirk Manski, MD</span></p>
    </a>  
</header>
<main> 
<article>
<nav role="navigation">
<div id="menuToggle">
<input type="checkbox" id="menuCheckbox" />
     <span></span>
    <span></span>
    <span></span>
<ul id="menu">
<li>
        <a href="https://www.urology-textbook.com/anatomy.html">
          <label for="menuCheckbox" onclick="this.parentNode.click();">Anatomy</label>
        </a>
      </li>
<li><a href="https://www.urology-textbook.com/signs-and-symptoms.html">Signs and Symptoms</a></li>
<li><a href="https://www.urology-textbook.com/examinations.html">Examinations</a></li>
<li><a href="https://www.urology-textbook.com/surgical-management.html">Surgical Management</a></li>
<li><a href="https://www.urology-textbook.com/pharmacology.html">Pharmacology</a></li>
<li><a href="https://www.urology-textbook.com/kidneys.html">Kidneys</a></li>
<li><a href="https://www.urology-textbook.com/ureters.html">Ureters</a></li>
<li><a href="https://www.urology-textbook.com/bladder.html">Bladder</a></li>
<li><a href="https://www.urology-textbook.com/prostate.html">Prostate</a></li>
<li><a href="https://www.urology-textbook.com/urethra.html">Urethra</a></li>
<li><a href="https://www.urology-textbook.com/penis.html">Penis</a></li>
<li><a href="https://www.urology-textbook.com/testes.html">Testes</a></li>
<li><a href="https://www.urology-textbook.com/adrenal-glands.html">Adrenal Glands</a></li>
<li><a href="https://www.urology-textbook.com/common-diseases.html">Common Diseases</a></li>
<li><a href="https://www.urology-textbook.com/urologic-surgery.html">Urologic Surgery</a></li>
<li><a href="https://www.urology-textbook.com/index-urology.html">Index</a></li>
<li><a href="https://www.urology-textbook.com/medical-abbreviations.html">Abbreviations</a></li>
<li><a href="https://www.urology-textbook.com/urology-news.html">News</a></li>
<li><a href="https://www.urology-textbook.com/links.html">Links</a></li>
</ul>

</div>
</nav>

<p id="brotkrumen">&nbsp;You are here: <a href="https://www.urology-textbook.com/index.html">Urology Textbook</a>  &gt; <a href="https://www.urology-textbook.com/pharmacology.html">Drugs in Urology</a> &gt; Botulinum Toxin A</p>

<h1>Botulinum Toxin A: Mechanism, Adverse Effects, Contraindications, and Dosage</h1>

<h2>Mechanism of Action of Botulinum Toxin A</h2> 
<p>Botulinum toxin inhibits the exocytosis of <a href="https://www.urology-textbook.com/bladder-function.html">acetylcholine and other neurotransmitters from cholinergic nerve terminals</a> (including at the neuromuscular junction, at postganglionic parasympathetic nerve endings in smooth muscle, in glands, and in afferent nerve fibers). Botulinum toxin cleaves SNARE proteins, which are responsible for exocytosis of neurotransmitters (e.g., SNAP-25). The most urologic experience exists with botulinum toxin type A (onabotulinumtoxinA, trade name Botox).</p> 

<h2>Urologic Indications for Botulinum Toxin A:</h2> 

<p>Botulinum toxin type A is indicated when conservative and pharmacologic therapy provides insufficient benefit or causes intolerable adverse effects in <a href="https://www.urology-textbook.com/neurogenic-lower-urinary-tract-dysfunction.html">neurogenic detrusor overactivity</a> and in <a href="https://www.urology-textbook.com/overactive-bladder.html">overactive bladder</a>. In selected neurogenic cases, clinicians may consider treatment of detrusor-sphincter dyssynergia as an alternative to sphincterotomy; this use is often off-label. </p>

<h2>Pharmacokinetics of Botulinum Toxin A</h2> 

<p>Injection of botulinum toxin type A directly into the target muscle (the <a href="https://www.urology-textbook.com/bladder-anatomy.html">detrusor muscle or the urethral sphincter</a>). The clinical effect typically begins within 3 to 14 days and reaches maximal benefit after about 2 to 6 weeks. The mean duration of effect is approximately 6 to 9 months, with substantial interindividual variability. </p> 


<h2>Adverse Effects of Botulinum Toxin A</h2> 
<ul title="Adverse Effects of Botulinum Toxin A">
<li>Hypersensitivity reactions (e.g., rash and urticaria; anaphylaxis is rare).</li>
<li>Possible systemic toxin effects (very rare): dysphagia, dysarthria, ptosis, diplopia, generalized muscle weakness, or respiratory symptoms. </li>
<li>Urologic adverse effects after detrusor injection include <a href="https://www.urology-textbook.com/urinary-tract-infection.html">urinary tract infections</a>, dysuria, <a href="https://www.urology-textbook.com/hematuria.html">gross hematuria</a>, increased post-void residual volume, and <a href="https://www.urology-textbook.com/urinary-retention.html">urinary retention</a>. In neurogenic detrusor overactivity, autonomic dysreflexia can also occur.</li>
</ul>

<h3>Drug Interactions:</h3> 

<p>Botulinum toxin type A can theoretically worsen muscle weakness when patients receive <a href="https://www.urology-textbook.com/gentamicin.html">aminoglycosides</a> or other medications that impair neuromuscular transmission. </p>


<h2>Contraindications to Intravesical Use of Botulinum Toxin</h2> 

<ul title="Contraindications of Botulinum Toxin A">
<li>Untreated urinary tract infection. </li>
<li>Urinary retention or a post-void residual volume greater than 200&nbsp;mL in patients who cannot or will not perform clean intermittent catheterization. </li>
<li>Clinically relevant coagulopathy.</li>
<li>Known hypersensitivity. </li>
<li>Use with caution in myasthenia gravis or Lambert-Eaton syndrome and in other neuromuscular disorders. </li>
</ul>

<h2>Dosing of Botulinum Toxin A in Urology</h2>  

<p>OnabotulinumtoxinA (BOTOX) and abobotulinumtoxinA (Dysport) have different urologic approvals depending on the country and indication. The dosages between the two preparations are different, and conversion is only possible to a limited extent. The dosing regimens below describe onabotulinumtoxinA (BOTOX). </p>

<h3>Overactive Bladder With Spontaneous Voiding:</h3> 
<p>Direct injection of 100 units onabotulinumtoxinA into the detrusor muscle (e.g., reconstitute 100 units in 10&nbsp;mL and administer 20 injections of 0.5&nbsp;mL, delivering 5 units per injection). Distribute the injections evenly throughout the detrusor wall and spare the trigone. If patients respond inadequately, reassess diagnosis, technique, and contributing factors and consider repeat treatment at an appropriate interval. </p> 

<h3>Detrusor Overactivity Without Spontaneous Voiding:</h3> 
<p>In patients with neurogenic detrusor overactivity and clean intermittent catheterisation, intradetrusor injection of 200 units of onabotulinumtoxinA can increase bladder capacity and reduce incontinence (e.g., reconstitute 200 units in 30&nbsp;mL and administer 30 injections of 1&nbsp;mL, delivering approximately 6.7 units per injection). If the response to treatment is insufficient, the dose may be increased to 300 units.</p>


<h3>Detrusor-Sphincter Dyssynergia:</h3>
<p>For treatment of an overactive external sphincter: transurethral injection of 100&nbsp;units of onabotulinumtoxinA into the sphincter region; this approach is often off-label.</p> 
  

<br>
<br>

<div id="ad-footer">
<!-- ad-footer -->
<ins class="adsbygoogle"
     style="display:inline-block;width:500px;height:250px"
     data-ad-client="ca-pub-9284927104423861"
     data-ad-slot="8746163219"></ins>
 <script>
     (adsbygoogle = window.adsbygoogle || []).push({});
</script>
</div>
<br><table id="navigation_unten">
<tr>
 
<td><a href="https://www.urology-textbook.com/methionine.html">Methionine</a></td>
<td><a class="nav4" href="https://www.urology-textbook.com/index-urology.html">Index</a></td>
<td><a class="nav3" href="https://www.urology-textbook.com/dapoxetine.html">Dapoxetine</a></td>
 
</tr>
</table>

<br>
<br>
Index: <a href="https://www.urology-textbook.com/index-urology-a.html">1&ndash;9</a> <a href="https://www.urology-textbook.com/index-urology-a.html">A</a> <a href="https://www.urology-textbook.com/index-urology-b.html">B</a> <a href="https://www.urology-textbook.com/index-urology-c.html">C</a> <a href="https://www.urology-textbook.com/index-urology-d.html">D</a> <a href="https://www.urology-textbook.com/index-urology-e.html">E</a> <a href="https://www.urology-textbook.com/index-urology-f.html">F</a> <a href="https://www.urology-textbook.com/index-urology-g.html">G</a> <a href="https://www.urology-textbook.com/index-urology-h.html">H</a> <a href="https://www.urology-textbook.com/index-urology-i.html">I</a> <a href="https://www.urology-textbook.com/index-urology-j.html">J</a> <a href="https://www.urology-textbook.com/index-urology-k.html">K</a> <a href="https://www.urology-textbook.com/index-urology-l.html">L</a> <a href="https://www.urology-textbook.com/index-urology-m.html">M</a> <a href="https://www.urology-textbook.com/index-urology-n.html">N</a> <a href="https://www.urology-textbook.com/index-urology-o.html">O</a> <a href="https://www.urology-textbook.com/index-urology-p.html">P</a> <a href="https://www.urology-textbook.com/index-urology-q.html">Q</a> <a href="https://www.urology-textbook.com/index-urology-r.html">R</a> <a href="https://www.urology-textbook.com/index-urology-s.html">S</a> <a href="https://www.urology-textbook.com/index-urology-t.html">T</a> <a href="https://www.urology-textbook.com/index-urology-u.html">U</a> <a href="https://www.urology-textbook.com/index-urology-v.html">V</a> <a href="https://www.urology-textbook.com/index-urology-w.html">W</a> <a href="https://www.urology-textbook.com/index-urology-xyz.html">X Y Z</a> 

<br>
<br>
<h3>References</h3>



<p>Cruz, F.; Herschorn, S.; Aliotta, P.; Brin, M.; 
        Thompson, C.; Lam, W.; Daniell, G.; Heesakkers, J. &amp; Haag-Molkenteller, C.
        Efficacy 
        and safety of onabotulinumtoxinA in patients with urinary incontinence due 
        to neurogenic detrusor overactivity: a randomised, double-blind, 
        placebo-controlled trial.<br><em>Eur Urol, </em><b>2011</b><i>, 60</i>, 
        742-750</p>
    
<p>Karsenty, G.; Denys, P.; Amarenco, G.; Seze, M. D.; 
        Gam&#233;, X.; Haab, F.; Kerdraon, J.; Perrouin-Verbe, B.; Ruffion, A.; 
        Saussine, C.; Soler, J.; Schurch, B. &amp; Chartier-Kastler, E.
        Botulinum 
        toxin A (Botox) intradetrusor injections in adults with neurogenic 
        detrusor overactivity/neurogenic overactive bladder: a systematic 
        literature review.<br><em>Eur Urol, </em><b>2008</b><i>, 53</i>, 275-287.</p>

    <p>Mangera, A.; Andersson, K.; Apostolidis, A.; Chapple, 
        C.; Dasgupta, P.; Giannantoni, A.; Gravas, S. &amp; Madersbacher, S.
        Contemporary 
        management of lower urinary tract disease with botulinum toxin A: a 
        systematic review of botox (onabotulinumtoxinA) and dysport 
        (abobotulinumtoxinA).<br><em>Eur Urol, </em><b>2011</b><i>, 60</i>, 784-795.</p>

<br>
<br>
<p><img src="https://images0.urology-textbook.com/deutsch.gif">&nbsp; Deutsche Version: <a href="https://www.urologielehrbuch.de/botulinumtoxin.html">Mechanismus, Nebenwirkungen und Kontraindikationen von Botulinum Toxin A</a></p>

<h3>Urology-Textbook.com – Choose the Ad-Free, Professional Resource</h3>
<p>This website is designed for physicians and medical professionals. It presents diseases of the genital organs through detailed text and images. Some content may not be suitable for children or sensitive readers. Many illustrations are available exclusively to Steady members. Are you a physician and interested in supporting this project? <a href="https://steady.page/de/urology/about">Join Steady to unlock full access</a> to all images and enjoy an ad-free experience. Try it free for 7 days&mdash;no obligation. </p>

<p><strong>New release:</strong> The first edition of the Urology Textbook as an e-book&mdash;ideal for offline reading and quick reference. With over 1300 pages and hundreds of illustrations, it’s the perfect companion for residents and medical students. After your 7-day trial has ended, you will receive a download link for your exclusive e-book.</p>
</article>
</main>
<footer class="grid">
    <ul id="footer-nav">
    		<li>Copyright by Dr. med. Dirk Manski </li>
		<li><a href="https://www.urology-textbook.com/privacy-policy.html">Privacy policy</a></li>
		<li><a href="https://www.urology-textbook.com/disclaimer.html">Disclaimer</a></li>
	</ul>
	<a class="steady-login-button" data-size="medium" data-language="en" style="display: none;"></a>
</footer>
</body>
</html>
